Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Ligand Expands OmniAb® Antibody Discovery Platform Through the Acquisitions of xCella Biosciences and Taurus Biosciences
Friday, September 11, 2020Ligand Pharmaceuticals Incorporated announces the acquisition of two privately held companies that strengthen and complement its OmniAb technology platform Ligand acquired xCella Biosciences Inc for million in cash plus potential earnouts and acquir...
Humanized Chicken Antibody Technology to Drive Next Generation of Integral Molecular's MPS Antibody Discovery Platform
Friday, September 11, 2020Integral Molecular announces the development of Humanized Chicken Antibody Technology hCAT and the incorporation of hCAT into the companys industryleading MPS antibody discovery platform for multipass membrane proteins
AgeX Therapeutics and Lineage Cell Therapeutics Announce Expansion of Agreement Related to ESI Clinical-grade Pluripotent Stem Cell Lines for Therapeutic Purposes
Thursday, September 10, 2020AgeX Therapeutics Inc a company focused on developing and commercializing innovative therapeutics for human aging and Lineage Cell Therapeutics Inc a clinicalstage biotechnology company developing novel cell therapies for unmet medical needs and ES C...
Jazz Pharmaceuticals Announces New Research Collaboration with Redx Pharma to Discover and Develop Two Targeted Cancer Therapies
Thursday, September 10, 2020Jazz Pharmaceuticals plcannounced that the company has signed a new research collaboration agreement with Redx Pharma plc AIM REDX to discover and develop drug candidates for two cancer targets in the RasRafMAP kinase MAPK pathway This research colla...
Exelixis and NBE-Therapeutics Enter Into Exclusive Collaboration and License Option Agreement to Discover and Develop Novel Antibody-Drug Conjugates for the Treatment of Cancer
Wednesday, September 09, 2020Exelixis Incand NBETherapeutics announced a partnership to discover and develop multiple antibodydrug conjugates ADCs for oncology applications by leveraging NBEs unique expertise and proprietary platforms in ADC discovery including sitespecific conj...
AnGes and Brickell Biotech Announce a Collaboration Agreement for the Development of a Novel DNA Vaccine Candidate for COVID-19 in the U.S.
Wednesday, September 09, 2020AnGes Inc announced a collaboration agreement with Brickell Biotech Inc Brickell a clinicalstage pharmaceutical company through which Brickell has the right to develop AnGes proprietary investigational adjuvanted plasmid DNA vaccine intended to prev...
AnHeart Licenses Two Clinical Stage Oncology Candidates from Daiichi Sankyo
Tuesday, September 08, 2020AnHeart Therapeutics Co Ltd a clinical stage oncology company focused on underserved patients in global markets has through its subsidiary AnHeart Therapeutics Inc entered into license agreements with Daiichi Sankyo Company Limited Daiichi Sankyo TYO...
Aridis Announces Agreement with the FDA on Updated Phase 2 Clinical Trial Design for AR-501
Tuesday, September 08, 2020Aridis Pharmaceuticals Inc a biopharmaceutical company focused on the discovery and development of novel antiinfective therapies to treat lifethreatening infections today announced it has reached an agreement with the US Food and Drug Administration...
Grifols to acquire Alkahest to enhance discovery research and development to identify innovative therapies
Monday, September 07, 2020Grifols a leading global producer of plasmaderived medicines and a leader in the development of innovative diagnostic solutions today announced it has entered into a transaction to acquire the remaining equity of Alkahest Inc in exchange for a total...
Ehave Signs Licensing Agreement to Enhance its Telemedicine Platform
Saturday, September 05, 2020Ehave Inc a provider of digital therapeutics delivering evidencebased therapeutic interventions to patients announced it is entering into a licensing agreement with a telemedicine solutions provider from a single integrated platform Under the terms...
